Punarnava for Liver Health

Preliminary evidence 12 studies

Research suggests that the studies provided do not actually examine Punarnava (Boerhavia diffusa) or its effects on liver health in any meaningful way. The 12 studies linked here cover unrelated topics including hepatitis B vaccination economics, fatty liver disease in South Asian populations, pancreatic cancer metastasis, dietary interventions for metabolic liver disease, surgical liver perfusion protocols, parasitic infections, and hepatitis C screening programs. The one study most adjacent to herbal supplementation examined a combination formula containing turmeric, dandelion, milk thistle, and ginger — not Punarnava — in a randomized controlled trial that reported improvements in liver enzyme markers, though that finding cannot be attributed to Punarnava specifically. Based on the evidence provided here, no conclusions about Punarnava and liver health can be drawn, and readers interested in this topic would need to consult research that directly investigates this botanical ingredient.

Related studies

Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.

Title Type Year Direction Match
Economic evaluation of delaying the infant hepatitis B vaccination schedule Other 2025 Neutral 67
Non-invasive <sup>2</sup> H-MRS reveals a greater liver fat contribution fr... Other 2025 Neutral 62
Liver Metastasis Risk and Timing in Pancreatic Cancer Patients Using Electron... Other 2025 Neutral 57
Reduced Onset of MASLD, MASH, and Advanced Liver Disease in patients who rece... Other 2025 Neutral 52
Ex Vivo Human Liver Hyperperfusion Model: Study Protocol to Understand the Pa... Other 2025 Neutral 47
Metabolic Dysfunction-associated Steatotic Liver Disease Exacerbates Heart Fa... Other 2025 Neutral 42
B-Mode ultrasound patterns and findings of the liver among hepatitis B and C ... Other 2025 Neutral 37
Micro-elimination of Hepatitis C virus (HCV) infection in the General Populat... Other 2025 Neutral 32
Long-Term Safety and Efficacy of a Highly Purified Plant-Based Nutraceutical ... Other 2025 27
Clinical outcomes associated with schistosome infection and alcohol use: a sy... Other 2025 Neutral 22
Underuse of hepatocellular carcinoma surveillance in patients with cirrhosis:... Other 2025 Neutral 17
Economic Evaluation of an Employee Health Screening Program for Hepatitis C V... Other 2025 Neutral 12

← Back to Punarnava

Medical Disclaimer: Noyemi provides information from published research for educational purposes only. This content is not medical advice and does not replace consultation with a qualified healthcare provider. Always consult your doctor before starting, stopping, or changing any supplement regimen, especially if you take medications or have existing health conditions.